Clinical Research

Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, and the Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, at Mount Sinai in New York, was involved in most of the late-breaking pulsed field ablation (PFA) trials at the Heart Rhythm Society (HRS) 2024 meeting. He offers an overview of the new data presented and his observations from using PFA. #HRS24 #HRS2024 #PFA #EPeeps

The future of electrophysiology: Reviewing key trends in PFA

Vivek Reddy, MD, was involved in most of the late-breaking pulsed field ablation trials at Heart Rhythm 2024. He spoke to Cardiovascular Business at the conference about those trials and what they mean going forward.

Thumbnail

How having ovaries removed before menopause affects brain structure

These changes are especially prevalent in women who have the surgery before the age of 40, new research suggests. 

artificial intelligence in cardiology

AI can help cardiologists predict death after TAVR—but there is a catch

It's clear that advanced AI algorithms will radically transform care for TAVR patients in the years ahead. For now, however, certain AI models may require too much data to be helpful on a consistent basis. 

How patients' focus affects data derived from functional MRI scans

As a person’s concentration dwindles during resting state or task-based sequences, the resultant brain activity observed on imaging could be misleading.

Thumbnail

1.6 million excess Black deaths owed to inequities in cardiac care, JACC report card reveals

A JACC report card highlights excess cardiovascular mortality among Black Americans and "persistent and tragic inequities" in cardiovascular care.

MRI could be key to diagnosing and treating depression

Researchers involved in the work are hopeful their findings will help patients find relief sooner.

Thumbnail

GBCA doses can be reduced by over 50% for some MRI exams

In some cases, contrast doses can be reduced by as much as 62% without sacrificing diagnostic quality.

Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.